Offsets |
Mar. 16, 2026
USD ($)
|
|---|---|
| Offset: 1 | |
| Offset Payment: | |
| Offset Claimed | true |
| Rule 457(p) Offset | true |
| Registrant or Filer Name | INNOCAN PHARMA Corp |
| Form or Filing Type | F-1 |
| File Number | 333-288899 |
| Initial Filing Date | Jul. 23, 2025 |
| Fee Offset Claimed | $ 6,107.30 |
| Security Type Associated with Fee Offset Claimed | Equity |
| Security Title Associated with Fee Offset Claimed | Ordinary shares, no par value |
| Unsold Aggregate Offering Amount Associated with Fee Offset Claimed | $ 17,471,776.00 |
| Termination / Withdrawal Statement | (7)On July 23, 2025, the registrant filed a registration statement on Form F-1, as subsequently amended (File No. 333-288899) (the "Prior Registration Statement") with the Securities and Exchange Commission registering an indeterminate number of securities with a proposed maximum aggregate offering price of $40,403,482. |
| Offset: 2 | |
| Offset Payment: | |
| Offset Claimed | true |
| Rule 457(p) Offset | true |
| Registrant or Filer Name | INNOCAN PHARMA Corp |
| Form or Filing Type | F-1 |
| File Number | 333-288899 |
| Initial Filing Date | Jul. 23, 2025 |
| Fee Offset Claimed | $ 78.27 |
| Security Type Associated with Fee Offset Claimed | Equity |
| Security Title Associated with Fee Offset Claimed | Ordinary shares issuable upon exercise of the common warrants |
| Unsold Aggregate Offering Amount Associated with Fee Offset Claimed | $ 21,839,720.00 |
| Termination / Withdrawal Statement | (7) On July 23, 2025, the registrant filed a registration statement on Form F-1, as subsequently amended (File No. 333-288899) (the "Prior Registration Statement") with the Securities and Exchange Commission registering an indeterminate number of securities with a proposed maximum aggregate offering price of $40,403,482. |
| Offset: 3 | |
| Offset Payment: | |
| Offset Claimed | true |
| Rule 457(p) Offset | true |
| Registrant or Filer Name | INNOCAN PHARMA Corp |
| Form or Filing Type | F-1 |
| File Number | 333-288899 |
| Initial Filing Date | Jul. 23, 2025 |
| Fee Offset Claimed | $ 0.20 |
| Security Type Associated with Fee Offset Claimed | Equity |
| Security Title Associated with Fee Offset Claimed | Ordinary shares issuable upon exercise of the Representative's Warrants |
| Unsold Aggregate Offering Amount Associated with Fee Offset Claimed | $ 1,091,986.00 |
| Termination / Withdrawal Statement | (7) On July 23, 2025, the registrant filed a registration statement on Form F-1, as subsequently amended (File No. 333-288899) (the "Prior Registration Statement") with the Securities and Exchange Commission registering an indeterminate number of securities with a proposed maximum aggregate offering price of $40,403,482. |
| Offset: 4 | |
| Offset Payment: | |
| Offset Claimed | false |
| Rule 457(p) Offset | true |
| Registrant or Filer Name | INNOCAN PHARMA Corp |
| Form or Filing Type | F-1 |
| File Number | 333-288899 |
| Filing Date | Jul. 23, 2025 |
| Fee Paid with Fee Offset Source | $ 6,107.30 |
| Offset Note | (8) Pursuant to Rule 457(p) under the Securities Act, the registration fee for this registration statement of $8,263.36 is being offset in part by the previously paid registration fee in connection with the Prior Registration Statement, which was withdrawn on February 23, 2026 and no securities were sold under the Prior Registration Statement. |
| Offset: 5 | |
| Offset Payment: | |
| Offset Claimed | false |
| Rule 457(p) Offset | true |
| Registrant or Filer Name | INNOCAN PHARMA Corp |
| Form or Filing Type | F-1 |
| File Number | 333-288899 |
| Filing Date | Aug. 04, 2025 |
| Fee Paid with Fee Offset Source | $ 78.27 |
| Offset Note | (8) Pursuant to Rule 457(p) under the Securities Act, the registration fee for this registration statement of $8,263.36 is being offset in part by the previously paid registration fee in connection with the Prior Registration Statement, which was withdrawn on February 23, 2026 and no securities were sold under the Prior Registration Statement. |
| Offset: 6 | |
| Offset Payment: | |
| Offset Claimed | false |
| Rule 457(p) Offset | true |
| Registrant or Filer Name | INNOCAN PHARMA Corp |
| Form or Filing Type | F-1 |
| File Number | 333-288899 |
| Filing Date | Sep. 30, 2025 |
| Fee Paid with Fee Offset Source | $ 0.20 |
| Offset Note | (8) Pursuant to Rule 457(p) under the Securities Act, the registration fee for this registration statement of $8,263.36 is being offset in part by the previously paid registration fee in connection with the Prior Registration Statement, which was withdrawn on February 23, 2026 and no securities were sold under the Prior Registration Statement. |